These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 22325340

  • 1. IL-10 and IFN-γ gene expression in chronic Chagas disease patients after in vitro stimulation with recombinant antigens of Trypanosoma cruzi.
    de Melo AS, de Lorena VM, de Moura Braz SC, Docena C, de Miranda Gomes Y.
    Cytokine; 2012 May; 58(2):207-12. PubMed ID: 22325340
    [Abstract] [Full Text] [Related]

  • 2. Cytokine levels in serious cardiopathy of Chagas disease after in vitro stimulation with recombinant antigens from Trypanosoma cruzi.
    Lorena VM, Lorena IM, Braz SC, Melo AS, Melo MF, Melo MG, Silva ED, Ferreira AG, Morais CN, Costa VM, Correa-Oliveira R, Gomes YM.
    Scand J Immunol; 2010 Dec; 72(6):529-39. PubMed ID: 21044127
    [Abstract] [Full Text] [Related]

  • 3. Increased levels of IgA antibodies against CRA and FRA recombinant antigens of Trypanosoma cruzi differentiate digestive forms of Chagas disease.
    Vasconcelos RH, Amaral FN, Cavalcanti MG, Silva ED, Ferreira AG, Morais CN, Gomes YM.
    Hum Immunol; 2010 Oct; 71(10):964-7. PubMed ID: 20659514
    [Abstract] [Full Text] [Related]

  • 4. Cellular immune response from Chagasic patients to CRA or FRA recombinant antigens of Trypanosoma cruzi.
    Lorena VM, Verçosa AF, Machado RC, Moitinho-Silva L, Cavalcanti MG, Silva ED, Ferreira AG, Correa-Oliveira R, Pereira VR, Gomes YM.
    J Clin Lab Anal; 2008 Oct; 22(2):91-8. PubMed ID: 18348314
    [Abstract] [Full Text] [Related]

  • 5. Inflammatory mediators from monocytes down-regulate cellular proliferation and enhance cytokines production in patients with polar clinical forms of Chagas disease.
    Gomes JA, Molica AM, Keesen TS, Morato MJ, de Araujo FF, Fares RC, Fiuza JA, Chaves AT, Pinheiro V, Nunes Mdo C, Correa-Oliveira R, da Costa Rocha MO.
    Hum Immunol; 2014 Jan; 75(1):20-8. PubMed ID: 24071371
    [Abstract] [Full Text] [Related]

  • 6. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection.
    Abel LC, Rizzo LV, Ianni B, Albuquerque F, Bacal F, Carrara D, Bocchi EA, Teixeira HC, Mady C, Kalil J, Cunha-Neto E.
    J Autoimmun; 2001 Aug; 17(1):99-107. PubMed ID: 11488642
    [Abstract] [Full Text] [Related]

  • 7. Immunoglobulin M antibodies against CRA and FRA recombinant antigens of Trypanosoma cruzi in chronic chagasic patients.
    Vasconcelos RH, Azevedo EA, Cavalcanti MG, Silva ED, Ferreira AG, Morais CN, Gomes YM.
    Hum Immunol; 2011 May; 72(5):402-5. PubMed ID: 21371515
    [Abstract] [Full Text] [Related]

  • 8. Dogs infected with the blood trypomastigote form of Trypanosoma cruzi display an increase expression of cytokines and chemokines plus an intense cardiac parasitism during acute infection.
    de Souza SM, Vieira PM, Roatt BM, Reis LE, da Silva Fonseca K, Nogueira NC, Reis AB, Tafuri WL, Carneiro CM.
    Mol Immunol; 2014 Mar; 58(1):92-7. PubMed ID: 24317279
    [Abstract] [Full Text] [Related]

  • 9. Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease.
    Vitelli-Avelar DM, Sathler-Avelar R, Teixeira-Carvalho A, Pinto Dias JC, Gontijo ED, Faria AM, Elói-Santos SM, Martins-Filho OA.
    Scand J Immunol; 2008 Nov; 68(5):516-25. PubMed ID: 18803607
    [Abstract] [Full Text] [Related]

  • 10. Differential regulation of lymphoproliferative responses to Trypanosoma cruzi antigen in patients with the cardiac or indeterminate form of Chagas disease.
    de Barros-Mazon S, Guariento ME, da Silva CA, Coffman RL, Abrahamsohn IA.
    Clin Immunol; 2004 Apr; 111(1):137-45. PubMed ID: 15093563
    [Abstract] [Full Text] [Related]

  • 11. Benznidazole treatment during early-indeterminate Chagas' disease shifted the cytokine expression by innate and adaptive immunity cells toward a type 1-modulated immune profile.
    Sathler-Avelar R, Vitelli-Avelar DM, Massara RL, Borges JD, Lana M, Teixeira-Carvalho A, Dias JC, Elói-Santos SM, Martins-Filho OA.
    Scand J Immunol; 2006 Nov; 64(5):554-63. PubMed ID: 17032249
    [Abstract] [Full Text] [Related]

  • 12. Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients.
    Gomes JA, Bahia-Oliveira LM, Rocha MO, Busek SC, Teixeira MM, Silva JS, Correa-Oliveira R.
    Infect Immun; 2005 Dec; 73(12):7960-6. PubMed ID: 16299288
    [Abstract] [Full Text] [Related]

  • 13. Development of chronic cardiomyopathy in canine Chagas disease correlates with high IFN-gamma, TNF-alpha, and low IL-10 production during the acute infection phase.
    Guedes PM, Veloso VM, Afonso LC, Caliari MV, Carneiro CM, Diniz LF, Marques-da-Silva EA, Caldas IS, Do Valle Matta MA, Souza SM, Lana M, Chiari E, Galvão LM, Bahia MT.
    Vet Immunol Immunopathol; 2009 Jul 15; 130(1-2):43-52. PubMed ID: 19211152
    [Abstract] [Full Text] [Related]

  • 14. Specific activation of CD4- CD8- double-negative T cells by Trypanosoma cruzi-derived glycolipids induces a proinflammatory profile associated with cardiomyopathy in Chagas patients.
    Passos LSA, Magalhães LMD, Soares RP, Marques AF, Nunes MDCP, Gollob KJ, Dutra WO.
    Clin Exp Immunol; 2017 Oct 15; 190(1):122-132. PubMed ID: 28543170
    [Abstract] [Full Text] [Related]

  • 15. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL, Antúnez MI, Abrami AA.
    Medicina (B Aires); 1999 Oct 15; 59 Suppl 2():84-90. PubMed ID: 10668248
    [Abstract] [Full Text] [Related]

  • 16. IL-10 mediates susceptibility to Trypanosoma cruzi infection.
    Reed SG, Brownell CE, Russo DM, Silva JS, Grabstein KH, Morrissey PJ.
    J Immunol; 1994 Oct 01; 153(7):3135-40. PubMed ID: 8089491
    [Abstract] [Full Text] [Related]

  • 17. Increase in the expression of CD4 + CD25+ lymphocytic T cells in the indeterminate clinical form of human Chagas disease after stimulation with recombinant antigens of Trypanosoma cruzi.
    de Moura Braz SC, de Melo AS, da Glória Aureliano de Melo Cavalcanti M, Martins SM, de Oliveira W, da Silva ED, Ferreira AG, de Lorena VM, de Miranda Gomes Y.
    J Clin Immunol; 2014 Nov 01; 34(8):991-8. PubMed ID: 25205548
    [Abstract] [Full Text] [Related]

  • 18. Trypanosoma cruzi-specific IFN-γ-producing cells in chronic Chagas disease associate with a functional IL-7/IL-7R axis.
    Natale MA, Cesar G, Alvarez MG, Castro Eiro MD, Lococo B, Bertocchi G, Albareda MC, Laucella SA.
    PLoS Negl Trop Dis; 2018 Dec 01; 12(12):e0006998. PubMed ID: 30517089
    [Abstract] [Full Text] [Related]

  • 19. Troponin T autoantibodies correlate with chronic cardiomyopathy in human Chagas disease.
    Nunes DF, Guedes PM, Andrade Cde M, Câmara AC, Chiari E, Galvão LM.
    Trop Med Int Health; 2013 Oct 01; 18(10):1180-92. PubMed ID: 23906320
    [Abstract] [Full Text] [Related]

  • 20. [Role of cytokines in resistance and pathology in Trypanosoma cruzi infection].
    Laucella SA, Rottenberg ME, de Titto EH.
    Rev Argent Microbiol; 1996 Oct 01; 28(2):99-109. PubMed ID: 8768488
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.